RT Journal Article
A1 Elman, M.
A1 Elman, A.
A1 Glasser, A.
A1 Braver, D.
T1  Endophthalmitis Following Anti-VEGF Injections in a Retinal Practice Setting
JF Investigative Ophthalmology & Visual Science
JO Invest. Ophthalmol. Vis. Sci.
YR 2008
VO 49
IS 13
SP 976
OP 976
SN 1552-5783
AB    Evaluate the incidence, presentation, and outcome of patients presenting with endophthalmitis post intravitreal injection of anti-VEGF drugs     Retrospective review of charts of patients undergoing intravitreal anti-VEGF injections between December 1, 2004 and November 30, 2007.     Between December 1, 2004 and November 30, 2007, 1,303 Macugen injections were administered; one eye developed endophthalmitis. Between July 1, 2006 and November 30, 2007, 3,057 Lucentis injections were given; five eyes developed endophthalmitis. All patients were seen post-injection within the first 7 days after injection. Of the six patients developing endophthalmitis,three were asymptomatic and were diagnosed as a result of the scheduled followup.     Early detection may of endophthalmitis may be facilitated by scheduled followup examination.   
RD 3/2/2021